193 related articles for article (PubMed ID: 37155874)
21. Expression of heparan sulfate proteoglycans in murine models of experimental colitis.
Patterson AM; Delday MI; van Kuppevelt TH; Loh G; Blaut M; Haller D; Grant G; Kelly D
Inflamm Bowel Dis; 2012 Jun; 18(6):1112-26. PubMed ID: 21987406
[TBL] [Abstract][Full Text] [Related]
22. Tetraspanin-6 negatively regulates exosome production.
Ghossoub R; Chéry M; Audebert S; Leblanc R; Egea-Jimenez AL; Lembo F; Mammar S; Le Dez F; Camoin L; Borg JP; Rubinstein E; David G; Zimmermann P
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5913-5922. PubMed ID: 32108028
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-4 in Tumor Cell Motility.
Keller-Pinter A; Gyulai-Nagy S; Becsky D; Dux L; Rovo L
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34282767
[TBL] [Abstract][Full Text] [Related]
24. Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains: NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY.
Wang H; Jin H; Rapraeger AC
J Biol Chem; 2015 Oct; 290(43):26103-13. PubMed ID: 26350464
[TBL] [Abstract][Full Text] [Related]
25. MMP-9 mediated Syndecan-4 shedding correlates with osteoarthritis severity.
Bollmann M; Pinno K; Ehnold LI; Märtens N; Märtson A; Pap T; Stärke C; Lohmann CH; Bertrand J
Osteoarthritis Cartilage; 2021 Feb; 29(2):280-289. PubMed ID: 33246160
[TBL] [Abstract][Full Text] [Related]
26. Heparan sulfate proteoglycans are receptors for the cell-surface trafficking and biological activity of transglutaminase-2.
Scarpellini A; Germack R; Lortat-Jacob H; Muramatsu T; Billett E; Johnson T; Verderio EA
J Biol Chem; 2009 Jul; 284(27):18411-23. PubMed ID: 19398782
[TBL] [Abstract][Full Text] [Related]
27. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
[TBL] [Abstract][Full Text] [Related]
28. High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma.
Zhu Y; Zheng D; Lei L; Cai K; Xie H; Zheng J; Yu C
BMC Cancer; 2022 Oct; 22(1):1042. PubMed ID: 36199068
[TBL] [Abstract][Full Text] [Related]
29. The syndecan-4/protein kinase Cα pathway mediates prostaglandin E2-induced extracellular regulated kinase (ERK) activation in endothelial cells and angiogenesis in vivo.
Corti F; Finetti F; Ziche M; Simons M
J Biol Chem; 2013 May; 288(18):12712-21. PubMed ID: 23525101
[TBL] [Abstract][Full Text] [Related]
30. Membrane-anchored proteoglycans of mouse macrophages: P388D1 cells express a syndecan-4-like heparan sulfate proteoglycan and a distinct chondroitin sulfate form.
Yeaman C; Rapraeger AC
J Cell Physiol; 1993 Nov; 157(2):413-25. PubMed ID: 8227171
[TBL] [Abstract][Full Text] [Related]
31. Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer.
Davies EJ; Blackhall FH; Shanks JH; David G; McGown AT; Swindell R; Slade RJ; Martin-Hirsch P; Gallagher JT; Jayson GC
Clin Cancer Res; 2004 Aug; 10(15):5178-86. PubMed ID: 15297422
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of syndecan-4 upregulation by TNF-α in the endothelium-like EAhy926 cells.
Okuyama E; Suzuki A; Murata M; Ando Y; Kato I; Takagi Y; Takagi A; Murate T; Saito H; Kojima T
J Biochem; 2013 Jul; 154(1):41-50. PubMed ID: 23576453
[TBL] [Abstract][Full Text] [Related]
33. Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart.
Strand ME; Herum KM; Rana ZA; Skrbic B; Askevold ET; Dahl CP; Vistnes M; Hasic A; Kvaløy H; Sjaastad I; Carlson CR; Tønnessen T; Gullestad L; Christensen G; Lunde IG
FEBS J; 2013 May; 280(10):2228-47. PubMed ID: 23374111
[TBL] [Abstract][Full Text] [Related]
34. Multiple heparan sulfate chains are required for optimal syndecan-1 function.
Langford JK; Stanley MJ; Cao D; Sanderson RD
J Biol Chem; 1998 Nov; 273(45):29965-71. PubMed ID: 9792716
[TBL] [Abstract][Full Text] [Related]
35. The altered expression of syndecan 4 in the uninvolved skin of venous leg ulcer patients may predispose to venous leg ulcer.
Nagy N; Németh IB; Szabad G; Szolnoky G; Belsõ N; Bata-Csörgõ Z; Dobozy A; Kemény L; Széll M
Wound Repair Regen; 2008; 16(4):495-502. PubMed ID: 18638267
[TBL] [Abstract][Full Text] [Related]
36. Isolation and characterization of ryudocan and syndecan heparan sulfate proteoglycans, core proteins, and cDNAs from a rat endothelial cell line.
Shworak NW; Kojima T; Rosenberg RD
Haemostasis; 1993 Mar; 23 Suppl 1():161-76. PubMed ID: 8495865
[TBL] [Abstract][Full Text] [Related]
37. HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.
De Francesco MA; Baronio M; Poiesi C
J Biol Chem; 2011 Jun; 286(22):19541-8. PubMed ID: 21482826
[TBL] [Abstract][Full Text] [Related]
38. Syndecan Family Gene and Protein Expression and Their Prognostic Values for Prostate Cancer.
Santos NJ; Barquilha CN; Barbosa IC; Macedo RT; Lima FO; Justulin LA; Barbosa GO; Carvalho HF; Felisbino SL
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445387
[TBL] [Abstract][Full Text] [Related]
39. Role of syndecan-4 in breast cancer pathophysiology.
Onyeisi JOS; Lopes CC; Götte M
Am J Physiol Cell Physiol; 2022 Nov; 323(5):C1345-C1354. PubMed ID: 36094435
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-4 as a Pathogenesis Factor and Therapeutic Target in Cancer.
Onyeisi JOS; Lopes CC; Götte M
Biomolecules; 2021 Mar; 11(4):. PubMed ID: 33810567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
